IQVIA™ Real-World Insights Bibliography

Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee
Author(s): Robert Flynn1,2,*, Karin Hedenmalm1, Tarita Murray-Thomas3, Alexandra Pacurariu1, Peter Arlett1, Hilary Shepherd3, Puja Myles3, Xavier Kurz1
Affiliations(s): 1 Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands 2 Medicines Monitoring Unit (MEMO), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom 3 Clinical Practice Research Datalink (CPRD), MHRA, London, United Kingdom
Publication(s):  First published: 18 January 2020 https://doi.org/10.1002/cpt.1775
Document Type(s): Abstract, Article,
Countries: France, Germany, UK,
Click here for the abstract
C:
Y:
Database Validity and methodology, Drug safety, Health policy,
2020
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Author(s): Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publication(s):  IPVC, Barcelona, Spain, 23-27 March 2020
Document Type(s): Oral presentation,
Countries: China, France, Germany, Italy, Japan, Portugal, Spain,
C:
Y:
Infectious disease, Oncology,
2020
  L:
A:
English
Burden of illness, Observational study, Retrospective Field Study,
  Add to report
 
 
The prevalence of polypharmacy and the use of potentially inappropriate medications (PIMs): a cross-national study in five European countries - Preliminary Results
Author(s): Bennie M1, Elseviers M2, Schubert I3, Poluzzi E4, MacBride S5, Sermet C6, Jouaville Abrouk LS7, Menon S7, Trehony J7, Nasuti P7, Taxis K8
Affiliations(s): 1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde / Information Services Division, NHS National Services Scotland, UK 2 Clinical Pharmacology, Ghent University, Belgium Centre for Innovation and Care, University of Antwerp, Belgium 3 PMV Research Group, Faculty of Medicine and University Hospital of Cologne, University for Cologne, Germany 4 University of Bologna, Italy 5 NHS Greater Glasgow and Clyde, Scotland 6 IRDES, Institut de Recherche en Economie de la Santé, France 7 IQVIA Real World Solutions, London, UK / France 8 University of Groningen, PharmacoTherapy, Epidemiology and Economics, Groningen, The Netherlands
Publication(s):  European Drug Utilisation Resarch Group (EuroDURG) Conference 2020, Szeged, Hungary, 4-7 March 2020
Document Type(s): Poster,
Countries: Belgium, France, Germany, Italy, UK,
C:
Y:
Clinical practice, Public Health,
2020
  L:
A:
English
Population Based Study, Public Health, Retrospective database analysis,
  Add to report
 
 
Predictors of iron?deficiency anemia in primary care older adults: a real?world European multi?country longitudinal study
Author(s): Vetrano DL, Zucchelli A, Marconi E, Levi M, Pegoraro V, Cataldo N, Heiman F, Cricelli C, Lapi F
Affiliations(s): Vetrano DL: Department of Geriatrics, Catholic University of Rome and IRCCS Fondazione Policlinico ?A. Gemelli?, Rome, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy
Publication(s):  Aging Clin Exp Res (2020). https://doi.org/10.1007/s40520-019-01454-6
Document Type(s): Article,
Countries: Belgium, Germany, Italy, Spain,
Click here for the abstract
C:
Y:
Hematology,
2020
  L:
A:
English
Epidemiological study, Retrospective database analysis,
  Add to report
 
 
An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in Germany
Author(s): Jieling Chen1, Magaly Perez-Nieves1, Carolina Piras De Oliveira1, Erik Spaepen2, Beatrice Osumili3, Jiat Ling Poon1, Nanette Schloot2, Nuria Lara4, Laura Garcia Alvarez4, Montserrat Roset4
Affiliations(s): 1 Eli Lilly and Company, Indianapolis, US 2 Eli Lilly and Company, HaaPACS GmbH, Schriesheim, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Real World Solutions, Barcelona, Spain
Publication(s):  Postgraduate Medicine
Document Type(s): Article,
Countries: Germany,
Click here for the abstract
C:
Y:
Diabetes,
2020
  L:
A:
English
Compliance,
  Add to report
 
 
An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in Germany
Author(s): Jieling Chen1, Magaly Perez-Nieves1, Carolina Piras De Oliveira1, Erik Spaepen2, Beatrice Osumili3, Jiat Ling Poon1, Nanette Schloot2, Nuria Lara4, Laura Garcia Alvarez4, Montserrat Roset4
Affiliations(s): 1 Eli Lilly and Company, Indianapolis, US 2 Eli Lilly and Company, HaaPACS GmbH, Schriesheim, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Real World Solutions, Barcelona, Spain
Publication(s):  Postgraduate Medicine
Document Type(s): Article,
Countries: Germany,
Click here for the abstract
C:
Y:
Diabetes,
2020
  L:
A:
English
Compliance,
  Add to report
 
 
Cost-Effectiveness of the CELL-Based Quadrivalent Versus the Standard Egg-Based Quadrivalent Influenza Vaccine in Germany. Results of a Dynamic Transmission Modelling Approach
Author(s): Cai R, Gerlier L, Eichner M, Schwehm M, Majaram S, Mould-Quevedo J, Lamotte M.
Affiliations(s): IQVIA HEOR Zaventem
Publication(s):  ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 105463
Document Type(s): Poster,
Countries: Germany,
C:
Y:
Immunology and Vaccination,
2020
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
Investigation of factors considered in the health technology assessment conducted by regulatory authority in eight countries
Author(s): Akira Yuasa 1, Naohiro Yonemoto 1, Sven Demiya 2, Chihiro Foellscher 2, Shunya Ikeda 3 (rwesheorj 2)
Affiliations(s): 1) Pfizer Japan Inc., Tokyo, Japan 2) IQVIA Solutions Japan, Tokyo, Japan 3) Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan
Publication(s):  ISPOR 2020 Conference
Document Type(s): Abstract,
Countries: Australia, Canada, France, Germany, Italy, Japan, Spain, UK,
Click here for the abstract
C:
Y:

2020
  L:
A:
English
  Add to report
 
 
Adoption of immuno-oncology in NSCLC, a real-world study in EU5.
Author(s): Alejandra Martinez De Pinillos,?Isabel Ricote Lobera,?Cristina Martinez,?Caroline Anger,?Filippo Guglielmetti,?Roberto Jorge Bitton
Affiliations(s): IQVIA, London, United Kingdom; IQVIA, Madrid, Spain; IQVIA, Milan, Italy; IQVIA, Buenos Aires, Argentina
Publication(s):  Journal of Clinical Oncology?2019?37:15_suppl,?e20631-e20631
Document Type(s): Abstract,
Countries: France, Germany, Italy, Spain, UK,
Click here for the abstract
C:
Y:
Oncology,
2019
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data.
Author(s): Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K
Affiliations(s): IQVIA, Eli Lilly
Publication(s):  Journal. Diabetes Ther. 2019 Jun;10(3):1067-1088.
Document Type(s): Article,
Countries: Belgium, Canada, France, Germany, Italy, Netherlands ,
Click here for the abstract
C:
Y:
Diabetes,
2019
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
First Page Previous Page  2 of 50 Next Page Last Page